Causes of Bleeding Peptic Ulcer
The primary causes of bleeding peptic ulcers are Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin/antiplatelet agents, and anticoagulants 1, 2, 3.
Major Etiologic Factors
1. Helicobacter pylori Infection
- Remains a fundamental causative factor in peptic ulcer disease, though its prevalence in bleeding ulcers has been declining
- Recent data shows H. pylori was present in only 37% of bleeding ulcer patients 4
- Interestingly, H. pylori-negative status combined with aspirin/antiplatelet use carries the highest bleeding risk (OR 3.03) 5
- The decreasing prevalence of H. pylori in bleeding ulcers reflects changing epidemiology, with drug-induced ulcers becoming more dominant
2. NSAIDs
- The most prevalent risk factor in contemporary practice, with 80% of bleeding ulcer patients using risk medications 4
- NSAIDs cause ulcers through both systemic COX inhibition (reducing protective prostaglandins) and direct mucosal injury
- The bleeding risk is higher for NSAID-related ulcers than H. pylori ulcers because NSAIDs' antiplatelet effects impair clotting 6
- All NSAIDs carry risk; no anti-inflammatory drug, including selective COX-2 inhibitors, is completely gastric-safe 6
3. Aspirin and Antiplatelet Agents
- Even low-dose aspirin (<325 mg/day) causes bleeding ulcers 6
- Clopidogrel and ticlopidine at standard doses also increase bleeding risk 6
- Aspirin/antiplatelet use was an independent risk factor for bleeding (OR 2.35) 5
- The combination of H. pylori-negative status with continuous aspirin/antiplatelet use creates the highest-risk scenario 5
4. Anticoagulants
- Anticoagulants can provoke bleeding from pre-existing ulcers throughout the entire GI tract 7
- Patients on anticoagulants typically have serious underlying conditions (prosthetic heart valves, deep vein thrombosis), making bleeding consequences potentially disastrous 7
Contributing Risk Factors
Patient-specific factors that amplify bleeding risk include:
- Male gender (OR 1.78) 5
- Alcohol consumption (OR 2.08) 5
- Current smoking 5
- History of previous peptic ulcer disease (OR 2.46) 5
- Age >65 years, with risk increasing further after age 75 6
- Comorbidities, particularly cardiovascular disease 4, 6
Critical Clinical Pitfall
Only 8.5% of bleeding ulcer patients were using prophylactic proton pump inhibitors (PPIs) before their bleeding episode 4. This represents a massive failure in preventive care, as high-risk patients on NSAIDs, aspirin, or antiplatelet agents should receive gastroprotection but rarely do in real-world practice.
Synergistic Risk
The interaction between risk factors is multiplicative rather than additive. Patients with combined risk factors (e.g., NSAID use + anticoagulation, or aspirin + history of ulcer bleeding) face exponentially higher bleeding risk 7, 6. Corticosteroid co-therapy further amplifies NSAID-related bleeding risk 6.
Idiopathic Ulcers
A small subset of bleeding ulcers occur in patients who are both H. pylori-negative and not using NSAIDs/aspirin—termed idiopathic peptic ulcers 2. These represent approximately 5-10% of cases and require investigation for other causes including stress, hypersecretory states, or unrecognized drug exposure.